Your partner in science for end-to-end CRDMO solutions
The In vitro Biology Group has the expertise to perform a variety of biochemical and cellular assays against varied target classes, including enzymes, GPCR’s, NHR’s and transporters.
The department is equipped with necessary infrastructure and updated technologies for in vitro pharmacology services to enable these assays, including sophisticated liquid-handling, compound-handling and assay-detection systems.
With a high ratio of PhD scientists with global exposure and long-standing discovery experience, Jubilant Biosys is well-placed to support target validation, assay development, screening and mechanism of action for first-in-class & best-in-class requirements.
Our experienced team of in vitro pharmacology brings strong problem-solving skills and expertise in a large variety of assays involving platforms mentioned above.
We offer extensive assay development and validation service required in the discovery process. Our biologists assist you with precise and adaptable assays to screen small molecules and support discovery from hit-to-lead, to preclinical candidate (PCC) declaration.
Jubilant Biosys has expertise in various therapeutic areas, including oncology, CNS, metabolic disorders, pain & inflammation.
We have delivered on novel requirements and supported over 85 IDD programs successfully, working with DNA, protein & RNA target classes and worked with leading Biotech & Pharma companies.